top
Please input keywords
RenNano: Fully Human Nanobody Mice Platform


Fully human heavy chain variable region and modified constant region



Robust immune response compared with RenMab mouse



Diversity of the antigen-specific antibodies discovered from RenNano





High binding affinity at nanomolar range



Good developability



Posters


AACR 2023: RenNano® Mice: A Heavy-Chain-Only Antibody Platform for the Generation of Nanobody Therapeutics


AACR 2023: Discovery of RenNano®-Derived Human Heavy-Chain-Only Antibodies That Cross the Blood-Brain-Barrier